AU2001295098A1 - Monoclonal antibody against ovarian carcinoma - Google Patents

Monoclonal antibody against ovarian carcinoma

Info

Publication number
AU2001295098A1
AU2001295098A1 AU2001295098A AU9509801A AU2001295098A1 AU 2001295098 A1 AU2001295098 A1 AU 2001295098A1 AU 2001295098 A AU2001295098 A AU 2001295098A AU 9509801 A AU9509801 A AU 9509801A AU 2001295098 A1 AU2001295098 A1 AU 2001295098A1
Authority
AU
Australia
Prior art keywords
monoclonal antibody
antibody against
ovarian carcinoma
against ovarian
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295098A
Inventor
Catharina Elizabeth Fick
Hannelore Frida Ursula Veenstra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2001295098A1 publication Critical patent/AU2001295098A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU2001295098A 2000-09-05 2001-09-04 Monoclonal antibody against ovarian carcinoma Abandoned AU2001295098A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA2000/2782 2000-09-05
ZA200002782 2000-09-05
PCT/ZA2001/000132 WO2002020620A2 (en) 2000-09-05 2001-09-04 Monoclonal antibody against ovarian carcinoma

Publications (1)

Publication Number Publication Date
AU2001295098A1 true AU2001295098A1 (en) 2002-03-22

Family

ID=25588774

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295098A Abandoned AU2001295098A1 (en) 2000-09-05 2001-09-04 Monoclonal antibody against ovarian carcinoma

Country Status (3)

Country Link
US (1) US7229780B2 (en)
AU (1) AU2001295098A1 (en)
WO (1) WO2002020620A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568698A1 (en) 2004-02-27 2005-08-31 Aventis Pharma Deutschland GmbH Pyrrole-derivatives as factor Xa inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059680A (en) 1986-11-24 1991-10-22 Centocor, Inc. Method of isolating ca 125 antigen
JPH02504517A (en) 1987-08-19 1990-12-20 セントカー・インコーポレーテツド Antigen associated with human ovarian carcinoma

Also Published As

Publication number Publication date
US7229780B2 (en) 2007-06-12
WO2002020620A3 (en) 2003-01-03
US20040259174A1 (en) 2004-12-23
WO2002020620A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2002251562A1 (en) Anti-CD40 monoclonal antibody
HUP0300841A3 (en) Agonist anti-trk-c monoclonal antibodies
EP1391464A4 (en) Anti-cd40 monoclonal antibody
IL156030A0 (en) Humanized antibodies
AU1174702A (en) Humanized anti-lt-beta-r antibodies
AU2001234125A1 (en) Antibody library
AU2001268855A1 (en) Single-domain antigen-binding antibody fragments derived from llama antibodies
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU1687500A (en) Antihuman vegf monoclonal antibody
AUPR395801A0 (en) Antibodies against cancer
AU2002365649A1 (en) Anti-dota antibody
AU2001246846A1 (en) Immunoassay of anti-hm1.24 antibody
AU4441799A (en) Monoclonal antibodies that recognize antigens associated with tumor metastasis
IL136459A0 (en) Antibody library
AU2001290860A1 (en) Spas-1 cancer antigen
AU2001246934A1 (en) Agonist antibodies
AU1598801A (en) HGF-SF monoclonal antibody combinations
AU2002221132A1 (en) Novel antibody
AU2001295098A1 (en) Monoclonal antibody against ovarian carcinoma
EP1455822A4 (en) Lyophilized monoclonal antibody compositions
AU2002217525A1 (en) Novel monoclonal antibody
EP1446416A4 (en) Tumor specific monoclonal antibodies
AUPQ599300A0 (en) Monoclonal antibody and uses therefor
GB0029846D0 (en) Monoclonal antibody
GB0030139D0 (en) Monoclonal antibody